Nephrology News and Research

RSS

Nephrology is a branch of internal medicine and pediatrics dealing with the study of the function and diseases of the kidney.

Study shows how rotavirus leads to severe gastrointestinal disease

Rotavirus is a major cause of diarrhea and vomiting, especially in children, that results in approximately 128,000 deaths annually.

20 Nov 2020

Genetic modification in ‘coat’ of fatal brain virus may allow it to escape antibodies

A genetic modification in the 'coat' of a brain infection-causing virus may allow it to escape antibodies, according to Penn State College of Medicine researchers.

20 Nov 2020

High cost of drugs could lead to more than 1.1 million deaths among Medicare recipients

More than 1.1 million Medicare patients could die over the next decade because they cannot afford to pay for their prescription medications, according to a new study released today by the West Health Policy Center, a nonprofit and nonpartisan policy research group and Xcenda, the research arm of the drug distributor AmerisourceBergen.

19 Nov 2020

Afro-Caribbean patients with end stage kidney disease more likely to be hospitalized with COVID-19

Afro-Caribbean people with end stage kidney disease (ESKD) are more likely to be hospitalized with COVID-19 than other ethnicities, a study has found.

19 Nov 2020

Researchers identify CLCN6 as disease gene for severe lysosomal neurodegenerative disorder

A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder. Scientists from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie and the Max Delbrück Center für Molekulare Medizin, together with an international team of researchers, have now analyzed the effect of a point mutation that was found in three unrelated affected children.

19 Nov 2020

Clinical Chemistry Analyzer Has Utility in Multiple Laboratory Settings and During COVID-19 Crisis with its Small Size and Vast Menu

The Medica EasyRA® benchtop clinical chemistry analyzer, distributed and serviced by Greensboro-based company, Carolina Liquid Chemistries Corp. (CLC), allows healthcare providers to test routine blood chemistries

From Carolina Liquid Chemistries Corp. 19 Nov 2020

People with heart disease can receive high-dose or standard-dose flu vaccines for protection

People with heart disease can receive either the high-dose or standard-dose flu vaccines for protection from heart or lung-related deaths or hospitalizations, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

18 Nov 2020

Study highlights the disproportionate burden of COVID-19 among Black, Hispanic patients

Research presented today by UT Southwestern cardiologists at the annual American Heart Association (AHA) Scientific Sessions 2020 showed that Black and Hispanic people were more likely to be hospitalized with COVID-19 than white patients, and that nonwhite men with cardiovascular disease or risk factors were more likely to die.

18 Nov 2020

Overweight and obesity in younger people associated with higher risk of severe COVID-19

Being younger doesn't protect against the dangers of COVID-19 if you are overweight, according to a new study from UT Southwestern.

17 Nov 2020

An acebuchin-oil-enriched diet helps to reduce arterial blood pressure

An acebuchin-oil-enriched diet helps to reduce arterial blood pressure, as shown by a study carried out by the Cardiovascular Physiopathology research group at the Physiology Department of the University of Seville.

17 Nov 2020

Investigational drug helped improve heart health in patients with chronic conditions

The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with Type 2 diabetes and chronic kidney disease, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Researchers report encouraging results from in vitro combination therapy against COVID-19

Researchers at Karolinska Institutet in Sweden report promising results from an in vitro combination therapy against COVID-19.

17 Nov 2020

Short bursts of intense exercise could help people get fit in time for summer

Short bursts of intense exercise – known as HIIT – could help you get back into shape by summer and stay that way, a UNSW Sydney exercise physiology researcher says.

17 Nov 2020

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.

16 Nov 2020

Short bursts of exercise elicit widespread changes in the body's levels of metabolites

Short bursts of physical exercise induce changes in the body's levels of metabolites that correlate to, and may help gauge, an individual's cardiometabolic, cardiovascular and long-term health, a study by Massachusetts General Hospital has found.

16 Nov 2020

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

Even when risk factors associated with cardiovascular disease are optimally controlled, adults with Type 2 diabetes still have a greater risk of developing cardiovascular disease compared to the general population, according to new research published today in the American Heart Association's flagship journal Circulation.

16 Nov 2020

Antifungal agent Itraconazole inhibits SARS CoV-2 in vitro

Itraconazole is a broad-spectrum antifungal agent that has been shown to have some in vitro activity against SARS-CoV-2 by a team of Belgian and German researchers.

16 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro

A team of researchers from the Northern Arizona University evaluated a new PARP inhibitor, stenoparib, which has recently advanced to Stage II of clinical trials to treat ovarian cancer. Their study, an initial report on in vitro stenoparib activity against human coronaviruses such as SARS-CoV-2, has been published on the preprint server bioRxiv*.

15 Nov 2020

Nephrology News and Research

Further Reading

Study shows how rotavirus leads to severe gastrointestinal disease

Genetic modification in ‘coat’ of fatal brain virus may allow it to escape antibodies

High cost of drugs could lead to more than 1.1 million deaths among Medicare recipients

Afro-Caribbean patients with end stage kidney disease more likely to be hospitalized with COVID-19

Researchers identify CLCN6 as disease gene for severe lysosomal neurodegenerative disorder

Clinical Chemistry Analyzer Has Utility in Multiple Laboratory Settings and During COVID-19 Crisis with its Small Size and Vast Menu

People with heart disease can receive high-dose or standard-dose flu vaccines for protection

Study highlights the disproportionate burden of COVID-19 among Black, Hispanic patients

Overweight and obesity in younger people associated with higher risk of severe COVID-19

An acebuchin-oil-enriched diet helps to reduce arterial blood pressure

Investigational drug helped improve heart health in patients with chronic conditions

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

Researchers report encouraging results from in vitro combination therapy against COVID-19

Short bursts of intense exercise could help people get fit in time for summer

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Short bursts of exercise elicit widespread changes in the body's levels of metabolites

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

Antifungal agent Itraconazole inhibits SARS CoV-2 in vitro

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

PARP inhibitor, stenoparib inhibits pre- and post-entry processes of SARS-CoV-2 in vitro

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News